(Q27681399)

English

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer

scientific article

Statements

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer (English)
0 references
Richard T Lewis
0 references
Christiane M Bode
0 references
Deborah M Choquette
0 references
Michele Potashman
0 references
Karina Romero
0 references
John C Stellwagen
0 references
Yohannes Teffera
0 references
Earl Moore
0 references
Douglas A Whittington
0 references
Hao Chen
0 references
Linda F Epstein
0 references
Renee Emkey
0 references
Paul S Andrews
0 references
Violeta L Yu
0 references
Douglas C Saffran
0 references
Man Xu
0 references
Allison Drew
0 references
Patricia Merkel
0 references
Steven Szilvassy
0 references
Rachael L Brake
0 references
26 July 2012
0 references
55
0 references
14
0 references
6523-40
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit